CSIM Evaluation - Keynote Addresses

CSIM Evaluation Form - Keynote Addresses

Your feedback is invaluable and will help us improve the meeting and plan future educational activities.

Friday, November 3, 2017
Extended Workshops - 1200 - 1340

Clinical Research in 2017: Why it Still Matters
Dr. James Douketis, 2017 Dr. David Sackett Senior Investigator Award Recipient
Objectives:
·     Demonstrate creative thinking in a technology-saturated world
·     Recite some do’s and don’ts for aspiring clinical investigators
·     Identify why clinical research matters to you

Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again?
Dr. Emily Gibson McDonald, 2017 New Senior Investigator Award Recipient
Objectives:
·     Describe the scope of the problem
·     Review Dopplers and CT pulmonary angiograms in a tertiary care institution
·     Identify unnecessary anticoagulation of subsegmental pulmonary embolisms
·     Reduce the over investigation and over treatment of VTE

To thank you for completing these evaluation forms, we will hold a daily draw for a $25 Starbucks gift card. If you wish to enter, please indicate your name and email address. Winners will be announced on-site at the meeting and on social media.

Participation is optional; if you do not wish to participate, leave the following two fields blank.

One entry per session evaluated. Contact information will only be used for draw purposes. Survey responses are anonymous.

Question Title

* 1. Your Name

Question Title

* 2. Your Email Address

Question Title

* 3. Please rate this session as follows

	Poor	Fair	Satisfactory	Good	Excellent
Scientific content of this presentation	Scientific content of this presentation Poor	Scientific content of this presentation Fair	Scientific content of this presentation Satisfactory	Scientific content of this presentation Good	Scientific content of this presentation Excellent
Usefulness/practicality of this presentation	Usefulness/practicality of this presentation Poor	Usefulness/practicality of this presentation Fair	Usefulness/practicality of this presentation Satisfactory	Usefulness/practicality of this presentation Good	Usefulness/practicality of this presentation Excellent
Adequate time for questions/discussion	Adequate time for questions/discussion Poor	Adequate time for questions/discussion Fair	Adequate time for questions/discussion Satisfactory	Adequate time for questions/discussion Good	Adequate time for questions/discussion Excellent
Speaker effectiveness: Dr. James Douketis	Speaker effectiveness: Dr. James Douketis Poor	Speaker effectiveness: Dr. James Douketis Fair	Speaker effectiveness: Dr. James Douketis Satisfactory	Speaker effectiveness: Dr. James Douketis Good	Speaker effectiveness: Dr. James Douketis Excellent
Speaker effectiveness: Dr. Emily Gibson McDonald	Speaker effectiveness: Dr. Emily Gibson McDonald Poor	Speaker effectiveness: Dr. Emily Gibson McDonald Fair	Speaker effectiveness: Dr. Emily Gibson McDonald Satisfactory	Speaker effectiveness: Dr. Emily Gibson McDonald Good	Speaker effectiveness: Dr. Emily Gibson McDonald Excellent

Question Title

* 4. Session objectives were met

	Not at all	Partially	Mostly	Completely
Clinical Research in 2017: Why it Still Matters	Clinical Research in 2017: Why it Still Matters Not at all	Clinical Research in 2017: Why it Still Matters Partially	Clinical Research in 2017: Why it Still Matters Mostly	Clinical Research in 2017: Why it Still Matters Completely
Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again?	Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again? Not at all	Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again? Partially	Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again? Mostly	Too Much Medicine and Venous Thromboembolic Disease: How Can We Make Things Well Again? Completely

Question Title

* 5. Outcomes: As a result of attending this session, are you planning to

	Yes	No	Maybe
Discuss the session with your colleagues	Discuss the session with your colleagues Yes	Discuss the session with your colleagues No	Discuss the session with your colleagues Maybe
Pursue additional learning activities	Pursue additional learning activities Yes	Pursue additional learning activities No	Pursue additional learning activities Maybe
Complete a Personal Learning Project (PLP)	Complete a Personal Learning Project (PLP) Yes	Complete a Personal Learning Project (PLP) No	Complete a Personal Learning Project (PLP) Maybe

What new information did you learn from this session; what changes will you make as a result?

Question Title

* 6. Bias and Balance

	Yes	No	Unsure
The content of this presentation was scientifically valid and balanced	The content of this presentation was scientifically valid and balanced Yes	The content of this presentation was scientifically valid and balanced No	The content of this presentation was scientifically valid and balanced Unsure
This session WAS FREE from indicators of undue industry bias	This session WAS FREE from indicators of undue industry bias Yes	This session WAS FREE from indicators of undue industry bias No	This session WAS FREE from indicators of undue industry bias Unsure
This session WAS FREE from indicators of undue personal/other bias	This session WAS FREE from indicators of undue personal/other bias Yes	This session WAS FREE from indicators of undue personal/other bias No	This session WAS FREE from indicators of undue personal/other bias Unsure

If you feel there were indicators of bias, please describe:
(Note: Bias is defined as "a personal judgment in favor of a specific proprietary business interest or a commercial interest.")

Question Title

* 7. General Comments

Question Title

* 8. Topic suggestions for future conferences (please be as specific as possible)

Question Title

* 9. Feedback

Check here if you would like someone to contact you about your feedback.

If yes, please provide your email address

An evaluation form for general conference feedback is available on the CSIM website and will also be emailed to you after the conference.

Thank you for your feedback.